User: Guest

LYMPHOMA THERAPEUTICS

Global Market Trajectory & Analytics

MCP-6298

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

7794
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1091
Interactions with Platform & by Email

PARTICIPANTS

234
Unique # Participated

VALIDATIONS

106
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

231

EDITION

17

PRICE

USD $5450


Amid the COVID-19 crisis, the global market for Lymphoma Therapeutics estimated at US$14.9 Billion in the year 2020, is projected to reach a revised size of US$23.6 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Hodgkin Lymphoma (HL), one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Hodgkin Lymphoma (NHL) segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The Lymphoma Therapeutics market in the U.S. is estimated at US$4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.We bring years of research experience to this 17th edition of our report. The 231-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Amgen, Inc.; Astellas Pharma, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Celgene Corporation; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Forma Therapeutics, Inc.; GlaxoSmithKline PLC; Immunomedics, Inc.; Johnson & Johnson; Merck & Co., Inc.; Pfizer, Inc.; Seattle Genetics, Inc.; Spectrum Pharmaceuticals; Transgene SA
» Disease Type [Hodgkin Lymphoma (HL), and Non-Hodgkin Lymphoma (NHL)]
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Lymphoma Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Lymphoma Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lymphoma Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Lymphoma Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Hodgkin Lymphoma (HL) (Disease Type) World Market by Region/Country in US$ Million: 2018 to 2025
Hodgkin Lymphoma (HL) (Disease Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Hodgkin Lymphoma (HL) (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Non-Hodgkin Lymphoma (NHL) (Disease Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Non-Hodgkin Lymphoma (NHL) (Disease Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Non-Hodgkin Lymphoma (NHL) (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Lymphoma Therapeutics Market Share (in %) by Company: 2019 & 2025
United States Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
Lymphoma Therapeutics Market in the United States by Disease Type: A Historic Review in US$ Million for 2009-2017
United States Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Canada
Canadian Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
Canadian Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
Lymphoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
Japan
Japanese Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
Japanese Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
China
Chinese Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Historic Market Analysis in China in US$ Million by Disease Type: 2009-2017
Chinese Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European Lymphoma Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Lymphoma Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Lymphoma Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Lymphoma Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
Lymphoma Therapeutics Market in Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
European Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
France
Lymphoma Therapeutics Market in France by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
French Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
French Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Germany
Lymphoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
German Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
German Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Italy
Italian Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Historic Market Analysis in Italy in US$ Million by Disease Type: 2009-2017
Italian Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
United Kingdom Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Spain
Spanish Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
Spanish Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
Lymphoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
Russia
Russian Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
Lymphoma Therapeutics Market in Russia by Disease Type: A Historic Review in US$ Million for 2009-2017
Russian Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
Lymphoma Therapeutics Market in Rest of Europe in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
Rest of Europe Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lymphoma Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Lymphoma Therapeutics Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Australia
Lymphoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
Australian Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
Australian Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
India
Indian Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
Indian Lymphoma Therapeutics Historic Market Review by Disease Type in US$ Million: 2009-2017
Lymphoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
South Korea
Lymphoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
South Korean Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
Lymphoma Therapeutics Market Share Distribution in South Korea by Disease Type: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
Rest of Asia-Pacific Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Latin America
Latin American Lymphoma Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
Lymphoma Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American Lymphoma Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Disease Type: 2009-2017
Latin American Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
Lymphoma Therapeutics Market in Argentina in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
Argentinean Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Brazil
Lymphoma Therapeutics Market in Brazil by Disease Type: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian Lymphoma Therapeutics Historic Market Scenario in US$ Million by Disease Type: 2009-2017
Brazilian Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Mexico
Lymphoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
Mexican Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
Mexican Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
Lymphoma Therapeutics Market in Rest of Latin America by Disease Type: A Historic Review in US$ Million for 2009-2017
Rest of Latin America Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Middle East
The Middle East Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lymphoma Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East Lymphoma Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018 to 2025
The Middle East Lymphoma Therapeutics Historic Market by Disease Type in US$ Million: 2009-2017
Lymphoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
Iran
Iranian Market for Lymphoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Disease Type for the Period 2009-2017
Iranian Lymphoma Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Israel
Israeli Lymphoma Therapeutics Market Estimates and Forecasts in US$ Million by Disease Type: 2018-2025
Lymphoma Therapeutics Market in Israel in US$ Million by Disease Type: A Historic Review for the Period 2009-2017
Israeli Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian Lymphoma Therapeutics Market Growth Prospects in US$ Million by Disease Type for the Period 2018-2025
Lymphoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Disease Type: 2009-2017
Saudi Arabian Lymphoma Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
Lymphoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
United Arab Emirates Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
Lymphoma Therapeutics Market Share Distribution in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
Rest of Middle East
Lymphoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disease Type for the Period 2018-2025
Rest of Middle East Lymphoma Therapeutics Historic Market Analysis in US$ Million by Disease Type: 2009-2017
Rest of Middle East Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Africa
African Lymphoma Therapeutics Market Estimates and Projections in US$ Million by Disease Type: 2018 to 2025
Lymphoma Therapeutics Market in Africa by Disease Type: A Historic Review in US$ Million for 2009-2017
African Lymphoma Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Total Companies Profiled : 33

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com